OHSU COVID-19 vaccine plan for high-risk health care workers
December 15, 2020
Oregon Health & Science University will be among the first “prepositioning” sites in Oregon to receive 975 doses of the Pfizer BioNTEch COVID-19 vaccine Tuesday, Dec. 15.
Actualización Sobre el Ensayo Clínico de OHSU de la Vacuna Contra el COVID-19
December 14, 2020
Individuals who have high risk for infection are being prioritized for enrollment into national study.
OHSU COVID-19 Vaccine Clinical Trial Update
December 14, 2020
Individuals who have high risk for infection are being prioritized for enrollment into national study.
Gov. Kate Brown names OHSU executive as special adviser for COVID-19 vaccination implementation
December 11, 2020
Connie Seeley tapped to help direct Oregon’s distribution strategy.
NBA ‘bubble’ reveals the ultimate home court advantage, study finds
December 11, 2020
OHSU study highlights the importance of paying attention to circadian rhythms.
Long-term study of mitochondrial replacement therapy in monkeys finds no adverse health effects
December 08, 2020
Findings add safety, efficacy support for gene therapy developed at OHSU.
Damage to brain cells reverberates to ‘bystander’ cells, study finds
December 08, 2020
OHSU scientists are first to document mechanism that can cause temporary but severe loss of nervous system function.
OHSU adjusts low-barrier test sites for COVID-19
December 07, 2020
First two hours daily will be reserved for priority groups.
OHSU physician honored for co-invention of eye-imaging technology
December 04, 2020
David Huang, M.D., Ph.D., recognized by Sanford and Susan Greenberg Prize to End Blindness.
Picker
December 03, 2020
Louis Picker, M.D., of the Vaccine and Gene Therapy Institute at Oregon Health & Science University, June 29, 2016. (OHSU/Boone Speed Photography)